Insider filing · NBIX
George J Morrow
Director
profile →
Neurocrine Biosciences, Inc.
NBIX · Healthcare · 59 filings in 24 months
ticker →
George J Morrow sold $2.2M of Neurocrine Biosciences (NBIX)
Executed Nov 25 2025, disclosed Nov 26 2025, 1 day later.
Value, as filed
$2.2M
15,000 sh × $143.37
Executed
Nov 25 2025
the trade date, as filed
Disclosed
Nov 26 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GMGeorge J Morrow (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $2.2M of NBIX (13,900 sh across 8 lots, as filed), executed Nov 2.
The name
NBIXHealthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by George J Morrow in NBIX
NBIXSALE
Neurocrine Biosciences, Inc.
$2.2M13,900 sh across 8 lots
Exec Nov 2
Filed Nov 3 · 6:52 PM ET